These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6201806)

  • 41. A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT).
    Droz JP; Kramar A; Caillaud JM; Bellet D; Wibault P; Court BH
    Prog Clin Biol Res; 1985; 203():269-70. PubMed ID: 2421329
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.
    von Eyben FE; Blaabjerg O; Petersen PH; Hørder M; Nielsen HV; Kruse-Andersen S; Parlev E
    J Urol; 1988 Nov; 140(5):986-90. PubMed ID: 2845154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor markers in testicular germ cell tumors related to the stage of the disease at the time of diagnosis.
    Jacobsen GK
    Oncodev Biol Med; 1983; 4(6):C39-44. PubMed ID: 6196749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serum lactate dehydrogenase 1 as marker for testicular germ tumors].
    von Eyben FE; Lindegaard-Madsen E; Blaabjerg O; Hyltoft Petersen P
    Lakartidningen; 1992 Nov; 89(47):4022-4. PubMed ID: 1334185
    [No Abstract]   [Full Text] [Related]  

  • 47. [Determination of total lactate dehydrogenase (LDH) activity and its isoenzymatic spectrum in malignant tumors of the testis].
    Akhverdova LN; Nanobashvili DM
    Urol Nefrol (Mosk); 1977; (1):53-5. PubMed ID: 841767
    [No Abstract]   [Full Text] [Related]  

  • 48. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Schatte EC; Lerner SP
    J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
    [No Abstract]   [Full Text] [Related]  

  • 49. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
    Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
    J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
    Kolev Y; Uetake H; Takagi Y; Sugihara K
    Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
    Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
    Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor markers in advanced nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Nochomovitz LE; Goldmann A; Fraley EE; Rosai J; Johnson K; Kennedy BJ
    Cancer; 1981 Feb; 47(3):572-6. PubMed ID: 6164464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
    Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
    J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.